Welcome Cure Secures 4 Crore in Pre-Series Funding Round

Written by Shaveta Arora, Arushi Sharma

Welcome Cure, a prominent player in the homeopathy healthcare sector, has successfully raised over 4 crores in a pre-series A funding round, with Inflection Point Ventures (IPV) leading the investment.

Welcome Cure Secures 4 Crore in Pre-Series Funding Round
Welcome Cure, a homeopathy healthcare provider, secures 4 crores in pre-series A funding.

Welcome Cure has secured over 4 crores in a pre-series A funding round led by Inflection Point Ventures (IPV), aiming to raise over 16 crores for operations expansion, talent acquisition, technological advancements, and marketing campaigns. IPV led the round, aiming for a total of 16 crores.

Welcome Cure offers sustainable, comprehensive healthcare solutions in the fragmented homeopathy market, including diagnosis, treatment, and monitoring, with a focus on preventive care and overall well-being through both online and offline services.

Dr Jawahar Shah, Founder, Welcome Cure says, “Homeopathy has been around for more than 200 years, grown consistently and served humanity. It enjoys acceptance from all socio-economic classes and has a wide presence across the world. As per WHO it is the 2nd largest system of medicine and used in over 100 countries.

In a $9 Billion+ market there is immense potential as it’s growing at over 18 per cent CAGR and there is a missing brand which is a name synonym to Homeopathy. Welcome Cure desires to do that and be that. Emerge as the 1st choice when anyone thinks of Homeopathy Care. With IPVs participation in Welcome Cure as an equity and growth investor we are poised to make this vision come to light.”

Share article